← Back to all signals
RESEARCH PAPER ANALYSIS

Assessing Barriers and Facilitators to Return to Work for Kidney Cancer Survivors: A 6-Month Longitudinal Study.

AI interpretation is pending for this paper.

Open original publication →
PMID39462710
JournalSeminars in oncology nursing
Publication Date2024-10-28
Ingested2026-08-02 12:02 AM
EXECUTIVE SUMMARY

What the AI sees

Not AI summarized yet.

WHY IT MATTERS

Research significance

Pending deeper interpretation.

ABSTRACT

Source abstract

OBJECTIVES: This study aimed to investigate the factors that impact the readiness and success of kidney cancer survivors returning to work, providing insights for healthcare professionals, employers, and policymakers. METHODS: A prospective longitudinal study was conducted at Sun Yat-sen University Cancer Center from April 2022 to June 2023. The study enrolled 282 kidney cancer survivors aged 18 to 60 who completed three surveys at 1, 3, and 6 months postsurgery. Data collection involved telephone interviews and self-administered questionnaires, capturing sociodemographic information, medical history, and employment status, while follow-up assessments tracked return-to-work readiness. The scales used for analysis included the Generalized Anxiety Disorder Scale, the Patient Health Questionnaire, the Return-to-Work Self-Efficacy Questionnaire, the Perceived Social Support Scale, and the Brief Fatigue Inventory. Generalized Estimation Equations were applied to identify significant factors, with both single-factor and multivariate analyses performed to pinpoint the most critical variables. RESULTS: Return-to-work rates at 1, 3, and 6 months postsurgery were 26.9%, 59.9%, and 76.2%, respectively. Higher levels of anxiety, lower self-efficacy, older age, and greater fatigue were associated with reduced return-to-work rates. Physically demanding jobs posed more barriers compared to nonmanual roles. Significant factors identified in multivariate analysis included anxiety, self-efficacy, fatigue, and the nature of the patient's work. CONCLUSION: Psychological, physical, and job-related factors play a crucial role in determining whether kidney cancer survivors can successfully return to work. Tailored support and flexible work arrangements could help kidney cancer survivors reintegrate into the workforce, leading to better long-term outcomes. IMPLICATION FOR NURSING PRACTICE: Nursing professionals can play a vital role in assessing and supporting kidney cancer survivors during their recovery process by addressing both psychological and physical factors. Incorporating return-to-work readiness into postoperative care plans, offering mental health support, and liaising with employers to create flexible working conditions could enhance the reintegration of survivors into the workforce.

SUPPORTING PAPER SET

32 more papers to review

Ranked by current scoring engine
1 Age- and Sex-Related Differences in Primary Cutaneous Lymphoma. Cutis 59.4 2 Evaluating the consequences of childhood adiposity on the human plasma proteome at four timepoints across the lifecourse. Nature communications 38.2 3 CReP-mediated control of eIF2α phosphorylation is a critical node in MYC-driven medulloblastoma. Nature communications 58.4 4 DICER1 genetics and their impact on the diagnosis and management of lung lesions: A scoping review. Paediatric respiratory reviews 63.4 5 Sex- and age-stratified pharmacovigilance of methotrexate-associated adverse events in pediatric leukemia: a FAERS-based study. Frontiers in medicine 66.72 6 Case Report: Dasatinib-associated chylothorax and occult Bartonella henselae infection in pediatric leukemia: a case report and systematic review. Frontiers in pharmacology 75.6 7 B7-H3-mediated immune regulation in cancer: biological functions and therapeutic opportunities. Frontiers in pharmacology 67.04 8 Machine learning prediction model for distant metastasis at diagnosis in pediatric neuroblastoma: development, interpretation, and temporal validation. Translational pediatrics 73.3 9 Lipid and immune profiles in children with systemic juvenile idiopathic arthritis: a case-control study with paired longitudinal comparison of disease activity. Translational pediatrics 71.0 10 Ethical dilemmas and intervention strategies in doctor-patient-family communication in end-of-life pediatric oncology: a narrative review. Translational pediatrics 63.6 11 Pediatric Large Cell/Anaplastic Medulloblastomas: Diagnostic Concordance and Multi-Classifier DNA Methylation Profiling, Including the In-House MAGIBU Framework. Neuropathology : official journal of the Japanese Society of Neuropathology 64.5 12 Under One Roof: Household Composition and Health-Related Quality of Life Among Cancer Survivors. Cancer medicine 65.5 13 The Role of Methylation Marker FAM19A4/mir124-2 and HPV Genotype in Active Surveillance of Women With Cervical Intraepithelial Neoplasia Grade 2 (CIN2). Journal of medical virology 71.9 14 Pediatric Liver Transplantation in the Treatment of Solid Liver Tumors: A Narrative Review. Pediatric transplantation 64.84 15 Medulloblastoma Spatial Transcriptomics Reveals Tumor Microenvironment Heterogeneity With High-Density Progenitor Cell Regions Correlating With High-Risk Disease. JCO precision oncology 65.6 16 From Cure to Quality of Life: The Shifting Frontier in Pediatric Acute Lymphoblastic Leukemia. Journal of the National Comprehensive Cancer Network : JNCCN 47.5 17 Adverse Family Outcomes in Children With B-Cell Acute Lymphoblastic Leukemia From the Multicenter Trial Children's Oncology Group AALL0932. Journal of the National Comprehensive Cancer Network : JNCCN 72.7 18 Pediatric conjunctival papilloma managed with staged multimodal therapy: a case report. BMC ophthalmology 50.74 19 Where Eastern Medicine Meets Western Medicine: A World Review of the Management of Chronic Cough. World journal of otorhinolaryngology - head and neck surgery 65.5 20 Nanoprobe-Enabled Precision Imaging and Panoramic Boundary Delineation in Retinoblastoma. Cancer innovation 63.5 21 Bridging therapy in pediatric and AYA patients under 25 years with relapsed/refractory B-ALL undergoing anti-CD19 CAR-T therapy: a multicenter retrospective study by the Spanish group GETH-TC. Bone marrow transplantation 82.98 22 Changes in pediatric oncology nurses' knowledge and observed mucormycosis-prevention practices following an educational programme: a one-group pretest-posttest study. BMC nursing 80.4 23 Pharmacologically targeting CDK12 induces BRCAness and synergizes with merestinib to exacerbate DNA damage in high-risk neuroblastoma. Cell reports 59.3 24 Atypical presacral masses in Currarino syndrome: a case series. Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery 54.5 25 First report of proven Fusarium brachygibbosum sinusitis in a paediatric patient with acute myeloblastic leukaemia. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 55.2 26 Interpreting the Association Between Plasma Citrulline and Bloodstream Infection in Pediatric Acute Myeloid Leukemia. European journal of haematology 47.5 27 Trust in Retinoblastoma Care: Understanding Parent-Physician Relationships in Collectivist, Low-Resource Settings. Pediatric blood & cancer 60.9 28 Combined Bulk and Single-Cell RNA Sequencing Reveals Alterations in the Immune Microenvironment and Candidate Immune-Related Genes Associated With Diagnosis and Relapse in Childhood B-Cell Acute Lymphoblastic Leukemia. Pediatric blood & cancer 60.32 29 Phase II study of selpercatinib in children and young adults with RET-altered tumors: Arm N of the NCI-COG Pediatric MATCH trial (APEC1621). The oncologist 81.9 30 Genetic insights into pediatric congenital pulmonary airway malformations: a 13-year single-center experience. Pediatric surgery international 61.9 31 A case report of pediatric Gardner syndrome and literature review. Skeletal radiology 51.1 32 Changes In body composition and subsequent risk of relapse In childhood hodgkin lymphoma. Journal of the National Cancer Institute 73.92
PATIENT-FRIENDLY SUMMARY

Assessing Barriers and Facilitators to Return to Work for Kidney Cancer Survivors: A 6-Month Longitudinal Study.

For education only—not personal medical advice.

Before you continue

AI-assisted research information

Neurocompute uses AI to summarize scientific papers, interpret research signals, and suggest relevant reference links. AI-generated content can be incomplete, misleading, or wrong, and generated links may be irrelevant or unavailable.

Our reviewed outputs have performed strongly to date, but past accuracy is not a guarantee. Verify summaries, scores, claims, and links against the original publication before relying on them.

This platform is for research and education only. It does not provide medical advice, diagnosis, treatment recommendations, or clinical guidance.

Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic